In last trading session, Upstream Bio Inc (NASDAQ:UPB) saw 0.32 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $8.64 trading at -$0.14 or -1.59% at ring of the bell on the day assigns it a market valuation of $464.78M. That closing price of UPB’s stock is at a discount of -240.97% from its 52-week high price of $29.46 and is indicating a premium of 40.51% from its 52-week low price of $5.14. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.38 million shares which gives us an average trading volume of 281.31K if we extend that period to 3-months.
Upstream Bio Inc (NASDAQ:UPB) trade information
Upright in the red during last session for losing -1.59%, in the last five days UPB remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $8.64 price level, adding 10.93% to its value on the day. Upstream Bio Inc’s shares saw a change of -47.45% in year-to-date performance and have moved -2.04% in past 5-day. Upstream Bio Inc (NASDAQ:UPB) showed a performance of 2.61% in past 30-days. Number of shares sold short was 3.94 million shares which calculate 13.12 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 75 to the stock, which implies a rise of 88.48% to its current value. Analysts have been projecting 75 as a low price target for the stock while placing it at a high target of 75. It follows that stock’s current price would drop -768.06% in reaching the projected high whereas dropping to the targeted low would mean a loss of -768.06% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 53.97% while estimates for its earnings growth in next 5 years are of 22.40%.
Upstream Bio Inc (NASDAQ:UPB)’s Major holders
Insiders are in possession of 19.74% of company’s total shares while institution are holding 89.41 percent of that, with stock having share float percentage of 111.41%. Investors also watch the number of corporate investors in a company very closely, which is 89.41% institutions for Upstream Bio Inc that are currently holding shares of the company.
On the other hand, Fidelity Securities Fund-Fidelity Small Cap Growth Fund and Fidelity Select Portfolios-Health Care Portfolio are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 1.23 shares of worth $10.6 million or 2.28% of the total outstanding shares. The later fund manager was in possession of 853.67 shares on Mar 31, 2025 , making its stake of worth around $7.38 million in the company or a holder of 1.59% of company’s stock.
